HLA-B52

Further information: HLA-serotype tutorial
B*5101-β2MG with bound peptide 1e27
major histocompatibility complex (human), class I, B52
Alleles B*5201, 5202, 5203, . . .
Structure (See HLA-B)
Shared data
Locus chr.6 6p21.31

HLA-B52 (B52) is an HLA-B serotype. The serotype identifies the more common HLA-B*52 gene products.[1]

B52 is a split antigen of the broad antigen B5, and is a sister type of B51. B*5201 likely formed as a result of a gene conversion event between another HLA-B allele and HLA-B*5101.[2] There are a number of alleles within the B*52 allele group.[3]

Serotype

Serotypes B52, B5, B51, and B53 recognition of HLA B*5201 gene product[4]
B*52 B52 B5 B52 B53 Sample
allele % % % % size (N)
*5201 84 2 7 1 2823
Alleles link-out to IMGT/HLA Databease at EBI
HLA *5201 frequencies
freq
ref. Population (%)
[5] China Yunnan Lisu21.7
[5] China Yunnan Nu18.6
[5] Bulgaria Gipsy18.2
[5] Venezuela Sierra de Perija Yucpa12.8
[5] India Andhra Pradesh Golla12.0
[5] Japan Central10.7
[5] Japan10.4
[5] Georgia Tibilisi Kurds10.3
[5] Mali Bandiagara8.3
[5] South Africa Natal Tamil8.2
[5] Israel Ashk. and Non-Ashk. Jews7.3
[5] India North Hindus6.7
[5] China Beijing6.1
[5] India New Delhi6.1
[5] India Mumbai Marathas5.6
[5] Tunisia Ghannouch5.5
[5] Thailand pop35.1
[5] India West Coast Parsis5.0
[5] India North Delhi4.9
[5] Mexico Mestizos4.9
[5] Argentina Toba Rosario4.7
[5] Mexico Zaptotec Oaxaca4.5
[5] USA Hispanic4.5
[5] China Qinghai Hui4.1
[5] China Inner Mongolia3.9
[5] China North Han3.8
[5] Oman3.8
[5] Senegal Niokholo Mandenka3.7
[5] Bulgaria3.6
[5] Thailand3.5
[5] Ivory Coast Akan Adiopodoume3.4
[5] Venezuela Perja Mountain Bari3.4
[5] Italy North pop 13.3
[5] Sudanese3.3
[5] Romanian3.2
[5] Singapore Riau Malay3.0
[5] Autonomous Region Tibetans2.8
[5] Russia Tuva pop 22.8
[5] South Korea pop 32.8
[5] Iran Baloch2.5
[5] Tunisia2.5
[5] Jordan Amman2.4
[5] USA Hawaii Okinawa2.4
[5] Singapore Javanese Indonesians2.0
[5] Spain Eastern Andalusia1.8
[5] Macedonia pop 41.6
[5] Uganda Kampala1.6
[5] Belgium1.5
[5] Mexico Guadalajara Mestizos pop21.5
[5] Singapore Thai1.5
[5] Brazil1.4
[5] China Yunnan Lisu1.4
[5] Azores Santa Maria and Sao Miguel1.3
[5] France South East1.2
[5] Italy North Pavia1.2
[5] Saudi Arabia Guraiat and Hail1.2
[5] Mexico Chihuahua State Tarahumara1.1
[5] Tunisia Tunis1.1
[5] Israel Arab Druse1.0
[5] Japan Ainu Hokkaido1.0
[5] Portugal Centre1.0
[5] Singapore Chinese1.0
[5] Taiwan Minnan pop 11.0
[5] USA Caucasian 1.0
[5] Azores Central Islands0.9
[5] China South Han0.9
[5] Macedonia pop 40.7
[5] Morocco Nador Metalsa Class I0.7
[5] Georgia Svaneti Svans0.6
[5] Ireland South0.6
[5] Italy Bergamo0.6

Alleles

There are 18 alleles, with 14 amino acid sequence variants in B52. Of these only 9 are frequent enough to have been reliably serotyped. B*5201 is the most common, but others have a large regional abundance.

Disease

In ulcerative colitis

HLA-B52 appears to have the strongest linkage to ulcerative colitis in Japan.[6][7] This form of disease is frequently found with Takayasu's arteritis.[8][9]

In Takayasu's arteritis

Takayasu's arteritis appears to have an independent link to B52 associated disease.[10][11] The association with B*5201 increases risk of pulmonary infarction, ischemic heart disease, aortic regurgitation, systemic hypertension, renal artery stenosis, cerebrovascular disease, and visual disturbance.[12]

References

  1. Marsh SG, Albert ED, Bodmer WF, et al. (2005). "Nomenclature for factors of the HLA system, 2004". Tissue Antigens. 65 (4): 301–69. doi:10.1111/j.1399-0039.2005.00379.x. PMID 15787720.
  2. Cox ST, McWhinnie AJ, Robinson J, et al. (January 2003). "Cloning and sequencing full-length HLA-B and -C genes" (PDF). Tissue Antigens. 61 (1): 20–48. doi:10.1034/j.1399-0039.2003.610103.x. PMID 12622774.
  3. Hayashi H, Ennis PD, Ariga H, et al. (January 1989). "HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain". J. Immunol. 142 (1): 306–11. PMID 2909619.
  4. derived from IMGT/HLA
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database: http://www.allelefrequencies.net". Tissue Antigens. 61 (5): 403–7. doi:10.1034/j.1399-0039.2003.00062.x. PMID 12753660. External link in |title= (help)
  6. Sugimura K, Asakura H, Mizuki N, et al. (February 1993). "Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis". Hum. Immunol. 36 (2): 112–8. doi:10.1016/0198-8859(93)90113-F. PMID 8096500.
  7. Nomura E, Kinouchi Y, Negoro K, et al. (September 2004). "Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis". Genes Immun. 5 (6): 477–83. doi:10.1038/sj.gene.6364114. PMID 15215890.
  8. Oyanagi, Hironobu; Ishihata, R; Ishikawa, H; et al. (February 1994), "Ulcerative colitis associated with Takayasu's disease", Intern. Med., 33 (2): 127129, doi:10.2169/internalmedicine.33.127, PMID 7912572
  9. Sato, R; Sato, Y; Ishikawa, H; et al. (December 1994), "Takayasu's disease associated with ulcerative colitis", Intern. Med., 33 (12): 759763, doi:10.2169/internalmedicine.33.759, PMID 7718956
  10. Kimura A, Kitamura H, Date Y, Numano F (August 1996). "Comprehensive analysis of HLA genes in Takayasu arteritis in Japan". Int. J. Cardiol. 54 Suppl: S61–9. doi:10.1016/s0167-5273(96)88774-2. PMID 9119528.
  11. Yoshida M, Kimura A, Katsuragi K, Numano F, Sasazuki T (August 1993). "DNA typing of HLA-B gene in Takayasu's arteritis". Tissue Antigens. 42 (2): 87–90. doi:10.1111/j.1399-0039.1993.tb02242.x. PMID 7903491.
  12. Kitamura H, Kobayashi Y, Kimura A, Numano F (October 1998). "Association of clinical manifestations with HLA-B alleles in Takayasu arteritis". Int. J. Cardiol. 66 Suppl 1: S121–6. doi:10.1016/S0167-5273(98)00159-4. PMID 9951811.
This article is issued from Wikipedia - version of the 5/31/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.